FDA Appoints Assistant Commissioner For Science Ahead Of Plan B Decision
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Center for Veterinary Medicine Deputy Director Linda Tollefson will oversee FDA's Offices of Women's Health and Orphan Products Development.
You may also be interested in...
FDA Women’s Health Director Resigns Over Plan B
Susan Wood says she can “no longer serve as staff when scientific and clinical evidence...has been overruled.”
FDA Women’s Health Director Resigns Over Plan B
Susan Wood says she can “no longer serve as staff when scientific and clinical evidence...has been overruled.”
Correction: FDA Office Of Women’s Health
The first major undertaking for new FDA Assistant Commissioner for Science Linda Tollefson under her duties as head of FDA's Office of Women's Health is likely to be responding to the agency's decision on the over-the-counter switch application for Barr's Plan B contraceptive